Posts of Sam Shahrokhi
Company News
Core One Labs Announces Vocan Assembles Equipment to produce biosynthesized Psilocybin
January 23, 2021
Vancouver, British Columbia, Canada – January 23, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
Core One Labs Completes Sale of Non-Core Assets
January 15, 2021
Vancouver, British Columbia, Canada – January 15, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
Core One Labs Announces Breakthrough in Solving Psilocybin Dosing Problems by Introducing Biosynthetic Psilocybin to its Patented Thinstrip Delivery Method
January 12, 2021
Vancouver, British Columbia, Canada – January 12, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more
Company News
Leading Microbiologist, Dr. Robert E.W. Hancock Appointed As Executive Chairman of Core One Labs Inc.
January 07, 2021
Vancouver, British Columbia, Canada – January 7, 2021 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company” or “Core One”)...
Read more
Company News
Core One Labs Completes Acquisition of Vocan Biotechnologies Inc.
December 31, 2020
Vancouver, British Columbia, Canada – December 31, 2020 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “Company”) is pleased to announce...
Read more